People

Each month, this series will focus on Mayo Clinic’s values and feature quotes and stories from our founders that exemplify those values. This month's featured values are Innovation and Excellence.

For 50 years, the Bernard H. van der Steen Trust has helped ease the financial burden of cancer patients in need at Mayo Clinic.

On the September 22 broadcast of Mayo Clinic Radio, Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic and Chair of the Cellular Therapeutics Cross-Disciplinary Group in the Mayo Clinic Cancer Center, explained how chimeric antigen receptor T-cell therapy (CAR T-cell therapy) works and where the research is headed.

In a recent Q&A in CAP Today, Mohamed Salama, M.D., Medical Director of Mayo Medical Laboratories, discusses the use of CD30 as a predictive marker for therapy.

Yi Lin, M.D., Ph.D., a hematologist at Mayo Clinic and Chair of the Cellular Therapeutics Cross-Disciplinary Group in the Mayo Clinic Cancer Center, spoke at the Individualizing Medicine Conference, "Advancing Care through Genomics," on CAR T-cell therapy. In this new cancer treatment, T cells are genetically modified to equip them to recognize and destroy cancer cells.

Dr. Charles W. Mayo's story isn't as well-known as some of his family members' stories, but his life of serving others and showing compassion to his patients made a lasting impression on those who knew him.

Aziza Nassar, M.D., was selected as the new Chair of the Florida Division of Laboratory Medicine. She will enter the role on September 19.

S. Vincent Rajkumar, M.D., has received the 2018 Distinguished Mayo Clinic Investigator Award. The Distinguished Mayo Clinic Investigator Award is presented to individuals whose research careers demonstrate evidence of great distinction, high distinguished scholarship, creative achievement, and excellence in education and administrative responsibilities.

Newly discovered BRCA1 mutations known as “variants of unknown significance” (or VUS) could be harmful, making a woman’s risk of developing breast cancer as high as 72%. Fergus Couch, Ph.D., Chair of the Division of Experimental Pathology and Laboratory Medicine at Mayo Clinic, discusses the issue.

Kevin Halling, M.D., Ph.D., a Consultant in Mayo Clinic's Division of Laboratory Genetics and Genomics, spoke at the Individualizing Medicine Conference: Advancing Care through Genomics, on RNA sequencing.

The story of Mayo Clinic's beginning is well-known to many, but until recently, Doug Hansen had no idea that his great-grandfather was among those killed in the storm.

Fifty years ago in July, Dr. Charles W. Mayo—“Dr. Chuck,” the gregarious and accomplished grandson of W. W. Mayo, whose father and uncle, Drs. Charlie and Will Mayo, made Mayo Clinic what it is today—died in a car wreck near Mayowood. The Post-Bulletin asked readers to share memories they have of Dr. Chuck and that era.

Allan Jaffe, M.D., Consultant and Chair of Mayo Clinic’s Division of Clinical Core Laboratory Services, with a joint appointment in the Division of Cardiovascular Diseases, was recently profiled in Clinical Chemistry's "Inspiring Minds" feature.